Thomas A. West - 05 Jun 2024 Form 4 Insider Report for Inogen Inc (INGN)

Reporting relationship: Director
Issuer ticker: INGN
Reported as of: 05 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jun 2024, 17:18:26 UTC
Prior SEC filing: 02 Jun 2023
Next SEC filing: 27 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Leslyn Cicekli, as Attorney-in-Fact

Key filing fact

Thomas A. West filed Form 4 for Inogen Inc (INGN) on 07 Jun 2024.

Key facts

This page summarizes Thomas A. West's Form 4 filing for Inogen Inc (INGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jun 2024, 17:18.

Change

Previous filing in this sequence was filed on 02 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INGN transaction

Common Stock

Award

Transaction value: $0
Shares: +21,871
Change %: +116%
Price: $0.000000
Shares after: 40,677
Date: 05 Jun 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule.